January 22, 2021
Willkie’s Paris office advised Qualium Investissement on the announced sale of IMV Technologies to Montagu Private Equity.
On January 20, Willkie client Qualium Investissement announced it had entered exclusive negotiations with Montagu Private Equity and management to sell its majority stake in IMV Technologies.
Based in Normandy, France, IMV Technologies is the world leader in the design, manufacture, distribution and service of equipment and supplies used in animal reproduction and animal reproductive and clinical imaging. Its Life Sciences division features products used in human medical research and assisted reproduction. With operations in France, Brazil, China, India, the Netherlands, Russia, South Africa, the United Kingdom and the United States, and a vast network of distributors across more than 120 countries, IMV Technologies generates more than 85% of its revenue internationally.
The Willkie deal team was led by partner Gabriel Flandin and included counsels Georges Balit, Charles-Antoine Erignac and Philippe Grudé.
